ASX Share rice
Wed 12 Aug 2020 - 10:50:am (Sydney)

ALT Share Price

ANALYTICA LIMITEDALTHealth Care Equipment & Services

ALT Company Information


Analytica Limited




Medical Appliances & Equipment

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment


320 Adelaide Street Brisbane QLD Australia 4000


61 7 3278 1950

Exec. Chairman:

Dr. Michael Monsour

Chief Exec. Officer:

Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE

CFO & Exec. Director:

Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICD

Product Devel. & Operations Mang.:

Ms. Chelsea Cornelius

VP of Global Marketing:

Ms. Megan Henken

Company Overview:

Analytica Limited designs, develops, and supplies medical devices in Australia, the United Kingdom, and the United States. The company's lead product is PeriCoach system, an e-health treatment system for women who suffer stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Analytica Autostart Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited is based in Brisbane, Australia.

ALT Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


ALT CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Income:


Total Cash From Operating Activities:




Change To Inventory:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


ALT Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Interest Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


ALT Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


ALT Share Price History

ALT News

25 Apr, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
27 Jan, 2020
Analytica Limited (ASX:ALT) shareholders should be happy to see the share price up 17% in the last week. But will that...
17 Jan, 2020
Cambridge Analytica whistleblower Brittany Kaiser has released new documents today that illuminate the initial jockeying between the company and Facebook as they discussed the need for Cambridge Analytica to delete data associated with 87 million Facebook users' profiles. The data was improperly obtained in 2014 by researchers with access to Facebook's developer platform who were being paid by Cambridge Analytica to obtain and process social media users' information for the purpose of targeting political ads. In December 2015 a Guardian article about Cambridge academic Dr Aleksandr Spectre (Kogan) outlined how he had acquired the Facebook profiles for research, and that Cambridge Analytica had improperly acquired that data.
06 Jan, 2020
More details are emerging about the scale and scope of disgraced data company Cambridge Analytica's activities in elections around the world -- via a cache of internal documents that's being released by former employee and self-styled whistleblower, Brittany Kaiser. The now shut down data modelling company, which infamously used stolen Facebook data to target voters for President Donald Trump’s campaign in the 2016 U.S. election, was at the center of the data misuse scandal that, in 2018, wiped billions off Facebook's share price and contributed to a $5BN FTC fine for the tech giant last summer.
03 Dec, 2019
Geoff Daly has been the CEO of Analytica Limited (ASX:ALT) since 2014. First, this article will compare CEO...
20 Oct, 2019
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
19 Sep, 2019
Analytica Limited (ASX:ALT) continues its loss-making streak, announcing negative earnings for its latest financial...
20 Aug, 2019
Some stocks are best avoided. We really hate to see fellow investors lose their hard-earned money. Anyone who held...